Future developments in medical diagnostics are linked with the increasing knowledge in molecular processes of dispositions of disease and disease development. Simultaneously, each improved diagnosis related to the individual results in a more individualized therapy.
The main emphasis of the competence field Theranostics is on products enabling highly efficient and personalized therapy accompanying in vitro and in vivo diagnosis or even combine diagnosis and therapy in situ. Smart materials diagnosing, supervising and treating physiologic processes and defects are therefore essential.
In line with current trends and requirements in the field of health, the focus is on companion and molecular diagnostics as well as multimodal imaging.